Post by Cyclo Therapeutics, A Rafael Company

The Phase 3 TransportNPC™ study was possible thanks to the commitment of families, patients, advocacy partners and the best and brightest healthcare providers in the world. Thank you for your commitment to this robust study! https://lnkd.in/eMtWbwiQ